Chemi Nutra has introduced a liquid, 100% water dispersible, stable, and patented form of Mediator Phosphatidic Acid (PA), called VitaSperse-PA.
Photo © Shutterstock.com/Mariyana M
Chemi Nutra (Austin, TX) has introduced a liquid, 100% water dispersible, stable, and patented form of Mediator Phosphatidic Acid (PA), called VitaSperse-PA. Mediator PA has a proven mechanism of action, where it activates and sustains mTOR signaling, which rapidly upregulates muscle protein synthesis and lipid metabolism. Research has shown that it can accelerate muscle mass and strength gains, as well as fat mass loss in men and women. Until now, Mediator PA has been used in powder formulations, two-piece hard-shell capsules, and soft gel capsule, but could not be used in liquid applications because it is a lipid-based compound.
VitaSperse-PA was developed in collaboration with Ingredient Innovations International (DBA 3i Solutions; Wooster, OH), a leader in ingredient dispersion technology. “Almost 20 years ago we began working with 3i Solutions, as they perfected a 100% water soluble, stable, concentrated, highly bioavailable, form of our SerinAid PhosphatidylSerine (PS), which has been used for about 10 years in commercially sold mental performance beverages and shots,” said Scott Hagerman, president of Chemi Nutra, in a press release. “With 3i Solutions’ demonstrated capabilities and our combined applications and marketing work in functional drinks of all types, we are excited that our branded, clinically proven, Mediator PA can now be easily and effectively added to beverages, shots, liquids, and gels - a rapidly evolving segment in the functional foods arena.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.